Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Ader

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Antimicrobial Agents and Chemotherapy|April 29, 2026
A step toward defining optimal liposomal amphotericin B treatment duration in pulmonary mucormycosis: results from emulated trialsAnne Coste, Olivier Paccoud, François Danion, et al.
Vaccine|July 27, 2024
A quick access to information on influenza burden and prevention in Lyon university hospital: A prospective QR code-based information campaign in 2022-2023Nagham Khanafer, Sylvain Oudot, Margot Maligeay, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2024
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective studyAurélie Jourdes, Elise Cellerin, Cyrille Touzeau, et al.
BMJ Medicine|November 3, 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trialKarine Lacombe, Thomas Hueso, Raphael Porcher, et al.
American Journal of Hematology|August 4, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European centerPierre Sesques, Emmanuelle Ferrant, Violaine Safar, et al.
Blood|September 22, 2020
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19Thomas Hueso, Cécile Pouderoux, Hélène Péré, et al.
The Lancet. Respiratory Medicine|February 24, 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Benjamin Speich, France Mentré, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 6, 2024
Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or neuromyelitis Optica spectrum disorder with Covid-19: A multicenter retrospective studyTanguy Dequidt, Quentin Richier, Céline Louapre, et al.
The Lancet. Microbe|March 5, 2026
Invasive aspergillosis in liver transplant recipients in France (2007-21): a nationwide, retrospective, matched case-control studyCoralie Le Hyaric, Cléa Melenotte, François Lefebvre, et al.
Medical Mycology|December 23, 2025
Multicenter Analysis of General presentations and Imaging features in Cerebral MUCORmycosis (MAGICMUCOR): towards different entitiesClémentine de La Porte, Corentin Provost, Anne Coste, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|April 29, 2026
A step toward defining optimal liposomal amphotericin B treatment duration in pulmonary mucormycosis: results from emulated trialsAnne Coste, Olivier Paccoud, François Danion, et al.
Vaccine|July 27, 2024
A quick access to information on influenza burden and prevention in Lyon university hospital: A prospective QR code-based information campaign in 2022-2023Nagham Khanafer, Sylvain Oudot, Margot Maligeay, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2024
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective studyAurélie Jourdes, Elise Cellerin, Cyrille Touzeau, et al.
BMJ Medicine|November 3, 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trialKarine Lacombe, Thomas Hueso, Raphael Porcher, et al.
American Journal of Hematology|August 4, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European centerPierre Sesques, Emmanuelle Ferrant, Violaine Safar, et al.
Blood|September 22, 2020
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19Thomas Hueso, Cécile Pouderoux, Hélène Péré, et al.
The Lancet. Respiratory Medicine|February 24, 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Benjamin Speich, France Mentré, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 6, 2024
Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or neuromyelitis Optica spectrum disorder with Covid-19: A multicenter retrospective studyTanguy Dequidt, Quentin Richier, Céline Louapre, et al.
The Lancet. Microbe|March 5, 2026
Invasive aspergillosis in liver transplant recipients in France (2007-21): a nationwide, retrospective, matched case-control studyCoralie Le Hyaric, Cléa Melenotte, François Lefebvre, et al.
Medical Mycology|December 23, 2025
Multicenter Analysis of General presentations and Imaging features in Cerebral MUCORmycosis (MAGICMUCOR): towards different entitiesClémentine de La Porte, Corentin Provost, Anne Coste, et al.
Pageof 17